Computer modeling and simulation for medical device evaluation has been pursued as a means for reducing the cost and scope of clinical trials while minimizing the risk of unforeseen adverse outcomes. Advances in computational technologies and algorithms have further enabled analysis with complex and realistic Bayesian models to be applied to clinical trials.
